Cardiac Catheterization: A Review for Pharmacists
Basics of pci
Percutaneous Coronary Intervention (PCI)
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial - The Lancet
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.,JAMA - X-MOL
Management of patients after primary percutaneous coronary intervention for myocardial infarction | The BMJ
After PCI for MI, 90-day prescriptions confer better medication adherence, fewer changes
Cardiac Catheterization: A Review for Pharmacists
Antiplatelet Agents in Acute Coronary Syndromes
Ticagrelor With or Without Aspirin After Complex PCI - ScienceDirect
Pharmacological management of STEMI post percutaneous coronary intervention
Genetic testing may help select antiplatelet medication after PCI: TAILOR- PCI
A Handbook of Primary PCI: No-Reflow Management | SpringerLink
Creating a Same-Day Discharge PCI Program Using Transradial | DAIC
EVEROLIMUSELUTING STENTS OR BYPASS SURGERY FOR LEFT MAIN
Medication at 30 days after PCI according to the clinical diagnosis | Download Table
Pharmacology before, during and after percutaneous coronary intervention | Heart
Antiplatelet therapy in coronary artery disease
References in Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial - The Lancet
Medications at discharge and at 1 year after the index PCI | Download Scientific Diagram
Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor
Long-term Care After Percutaneous Coronary Intervention: Focus on the Role of Antiplatelet Therapy - Mayo Clinic Proceedings
